-
Matthews latest England World Cup-winner out of Women's Six Nations
-
Race to find port for cruise ship battling deadly rodent virus
-
Celtic's O'Neill says Hearts' rise good for Scottish football
-
Ethiopia and Sudan accuse each other of attacks
-
Injured Mbappe faces backlash over Sardinia trip before Clasico
-
Vodafone to take full ownership of UK mobile operator
-
Stocks advance, oil falls as traders eye US-Iran ceasefire
-
Sabalenka ready to boycott Grand Slams over prize money
-
Boko Haram attack on Chad army base kills at least 24: military, local officials
-
US trade gap widens in March as AI spending boosts imports
-
US threatens 'devastating' response to any Iran attack on shipping
-
Murphy warns snooker hopefuls to 'work harder' to match Chinese stars
-
Race to find port for hantavirus-stricken cruise ship
-
Romanian pro-EU PM loses no-confidence motion
-
Edin Terzic to become Athletic Bilbao coach next season
-
Borthwick backed by RFU to take England to 2027 Rugby World Cup
-
EU hails 'leap forward' in ties with Russia's ally Armenia
-
German car-ramming suspect had mental health problems: reports
-
Pyongyang calling: North Korea shows off own-brand phones
-
Iran warns 'not even started' in Hormuz
-
World body in dark over allegations against China badminton chief
-
Asian stocks drop amid fears over US-Iran ceasefire
-
China fireworks factory explosion kills 26, injures 61
-
China hails 'our era' as Wu Yize's world snooker triumph goes viral
-
Ex-model accuses French scout of grooming her for Epstein
-
Timberwolves eclipse Spurs as Knicks rout Sixers
-
Taiwan leader says island has 'right to engage with the world'
-
Yoko says oh no to 'John Lemon' beer
-
Bayern's Kompany promises repeat fireworks in PSG Champions League semi
-
A coaching great? Luis Enrique has PSG on brink of another Champions League final
-
Top five moments from the Met Gala
-
Brunson leads Knicks in rout of Sixers
-
Retiring great Sophie Devine wants New Zealand back playing Tests
-
Ukraine pressures Russia as midnight ceasefire looms
-
Stocks sink amid fears over US-Iran ceasefire
-
G7 trade ministers set to meet but not discuss latest US tariff threat
-
Sherlock Holmes fans recreate fateful duel at Swiss falls
-
Premier League losses soar for clubs locked in 'arms race'
-
'Spreading like wildfire': Fiji grapples with soaring HIV cases
-
For Israel's Circassians, food and language sustain an ancient heritage
-
'Super El Nino' raises fears for Asia reeling from Middle East conflict
-
Trouble in paradise: Colombia tourist jewel plagued by violence
-
Death toll in Brazil small plane crash rises to three
-
Pulitzers honor damning coverage of Trump and his policies
-
Lawline Exits Beta and Launches Full AI Legal Platform for Businesses and Individuals
-
Digi Power X Signs AI Colocation Agreement with Leading AI Compute Company for 40 MW Data Center in Columbiana, Alabama
-
Camino Appointments Senior Management to Build and Operate the Puquios Copper Mine in Chile and for Corporate Development
-
LA fire suspect had grudge against wealthy: prosecutors
-
US-Iran ceasefire on brink as UAE reports attacks
-
Stars shine at Met Gala, fashion's biggest night
Coalition of states vows to protect access to abortion pill under Trump review
A coalition of attorneys general across states including New York, Minnesota and Arizona vowed Monday to protect access to mifepristone, the medication used in the majority of abortions in the United States.
The move comes as the Trump administration has reportedly launched a review into the medication's safety, in what many abortion rights' organizations have dubbed a blatant attempt to undermine health care access.
"The decision to reexamine access to this medication was made in response to a scientifically baseless letter and ignores decades of research that prove mifepristone is safe and effective," read the joint statement that included New York's Attorney General Letitia James, who co-led the coalition of 20 officials in the effort.
"Medical decisions should be left between patients, their families, and their providers – and they should be guided by science, not political agendas," the statement continued.
"If access to mifepristone is challenged, we will take action to protect it," it added.
Officials who co-signed the initiative represented Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New Mexico, Oregon, Rhode Island, Vermont, Washington state, and the District of Columbia.
Trump's health chief Robert F. Kennedy Jr and FDA Commissioner Marty Makary reportedly delivered a letter to 22 Republican attorneys general saying that the FDA was conducting its own review of the pill.
Proponents of reviewing mifepristone's safety have cited a study -- which was not peer-reviewed and published on a website, not in a scientific journal -- conducted by a conservative think-tank.
The Ethics & Public Policy Center (EPPC) says its priorities include "pushing back against the extreme progressive agenda while building a consensus for conservatives."
The medication has been used for 25 years in the United States. It is the most common method for abortion care and also routinely used for managing early miscarriage.
Mifepristone, which prevents pregnancy progression, and misoprostol, which empties the uterus, are approved to terminate a pregnancy up to 70 days of gestation in the United States.
C.Amaral--PC